By Adria Calatayud Roche Holding is scheduled to report results for 2023 on Thursday. Here is what you need to know. SALES FORECAST: The Swiss pharmaceutical.
Biotech deals are heating up as the year comes to an end, and analysts say the hot streak will likely continue in coming months. AbbVie and Roche Holding.
By Andrea Figueras Roche said it obtained positive results for its investigational treatment, inavolisib, as a first-line treatment for people with breast.